42 results about "Murine fibroblast" patented technology

The invention relates to a polyurethane material with protein adsorption resistance and cell adhesion resistance and a preparing method thereof. The material comprises a substrate and a modification layer. The substrate is made of polyurethane. The modification layer is obtained by polymerizing a vinyl pyrrolidone monomer on the surface of the substrate by utilization of an atom transfer radical polymerization technology. The material is prepared by steps of: subjecting the polyurethane to isocyanic acid esterification, performing amination, fixing a bromine initiator, and initiating graft polymerization of the vinyl pyrrolidone on the surface of the material. The surface of the polyurethane material prepared by the method has good hydrophilicity, good resistance to bovine serum fibrinogen adsorption, bovine serum albumin adsorption and lysozyme adsorption, and a function of resisting cell adhesion of mouse fibroblast cells (L-929), so that the polyurethane material is suitable for preparing biomedical catheter materials with complex shape structures.

The invention discloses a preparation method of a chitosan/polyvinyl alcohol sponge dressing containing nano-silver. The invention relates to an antibacterial dressing for therapy of trauma, and the chitosan/polyvinyl alcohol sponge dressing containing the nano-silver is prepared by adding nano-silver/polyvinyl alcohol solution and polyvinyl alcohol/chitosan blend solution. The obtained dressing has good biocompatibility and hemostatic and antibacterial effects, and can promote the wound healing; the product can accelerate the wound healing, release nano-silver particles in a sustained manner, be acted on regenerated bacteria constantly, have the lasting and high-efficient sterilization characteristics and avoid the drug resistance during the wound treatment process; the research on the toxic effect of the material to mouse fibroblasts shows that the product has no obvious toxicity to the cells and has the effect of promoting the growth of the cells; and preparation method has simple process equipment and low price of experimental raw materials and is conductive to industrialization.

This invention uses mesoporous silica nanoparticles and other nanostructured materials to formulate polyacrylate-based bone cement for achieving an enhanced and controlled elution of active ingredients such as antibiotics. This invention overcomes the limitation of low antibiotic release from commercial polyacrylate-based bone cements using for example, PMMA. In certain aspects, the formulation enables a sustained release of antibiotics from the bone cement over a period of 80 days and achieves 70% of total drug release, whereas the commercial antibiotic bone cement (e.g., SmartSet GHV) only releases about 5% of the antibiotics on the first day and subsequently an almost negligible amount. In addition, the mechanical properties of our formulated bone cements are well retained. The inventive bone cement exhibits good antibacterial properties and has very low cytotoxicity to mouse fibroblast cells.

The invention provides a sulfonic quantum dot/silk fibroin composite nanofiber membrane and a preparation method and application thereof. The preparation method comprises the following steps that degumming treatment is performed on natural silk, and silk fibroin is obtained; then, fibroin is dissolved in a lithium bromide water solution, and a silk fibroin sponge is obtained through dialysis, centrifugal and freeze drying; the silk fibroin sponge is dissolved into formic acid to be mixed to be uniform, then, a sulfonate graphene quantum dot water solution is ultrasonically and uniformly dispersed into a silk fibroin-formic acid solution, and a composite nanofiber membrane is prepared through electrostatic spinning equipment; mouse fibroblasts are used for performing cell viability evaluation on the composite nanometer member, and it shows that the composite nanometer membrane has the excellent biocompatibility. The prepared composite fiber membrane has the good biocompatibility and degradability, has the potential for promoting proliferation and differentiation of human bone marrow storm stem cells, and has the good biologic medical material application prospect.

The invention discloses a method for inducing mouse fibroblasts into cartilage by adopting a small-molecule composition. The method comprises the following steps: carrying out adherent culture on mouse embryo fibroblasts, removing a culture medium, slowly adding a chemical induction culture medium containing the small-molecule composition, carrying out culturing in the environment having the temperature of 37 DEG C and containing 3-8% of oxygen, 3-8 % of carbon dioxide and the balance of nitrogen, wherein the chemical induction culture medium containing the small-molecule composition is replaced every 2-3 days; carrying out continuous culturing for 4-12 days, thus obtaining intermediate state cells, wherein the small-molecule composition comprises an HDAC inhibitor, a GSK-3 inhibitor and aTGF-beta signal channel inhibitor; and transferring the intermediate state cells to a cartilage inducing medium, carrying out culturing in the environment having the temperature of 37 DEG C and containing 15-25% of oxygen, 3-8 % of carbon dioxide and the balance of nitrogen, wherein the cartilage inducing medium is replaced by the fresh cartilage inducing medium once every 3-4 days, and carryingout culturing for 14-28 days, thus obtaining a cartilage cell cluster. With the method provided by the invention, the problem that in the traditional methods, the fibroblasts can be induced to form cartilage cells through transdifferentiation only after an exogenous gene is introduced is solved, and the method provided by the invention is expected to be used for further solving the problem that seed cells of cartilage cells are in shortage or in-situ focus fibrosis exists.

The invention discloses a mouse fibroblast and an application thereof, and belongs to the field of cell biology. The cell is named mouse fibroblast MFC/HL-041 with the preservation number of CCTCC NO:C201714. The mouse fibroblast treated by mitomycin C or irradiated by radioactive rays is used for separation and subculture of normal primary epithelial cells and primary tumor cells. Obtained humanpulmonary normal primary epithelial cells and lung cancer primary epithelial cells are fresh and live in state, tight in arrangement, clear in cell boundary, high in stereoscopic impression and polygonal when examined under a microscope. The mouse fibroblast can be used for physiological study of human or animal normal cells, a virus infection model of in-vitro normal cells, drug sensitivity tests of the in-vitro normal cells for different drugs, drug screening for individualized treatment of cancer patients as well as research and development of new anti-cancer drugs.

The present invention discloses a method for preparing induced pluripotent stem cells by using a Xist Tale inhibitory transcription factor. Synergism of the transcriptional activator-like effectors (Tale)-based inhibitory transcription factor combined to a first intron region of Xist, Oct4, Sox2, Klf4 and c-Myc enhances the efficiency of induction of mouse fibroblasts to the induced pluripotent stem cells. Obtained iPSCs have typical pluripotent stem cell characteristics including involvement in the development of chimeric mice. The method actively promotes the clinical application and researches of the iPSCs, and provides new technical and theoretical bases for studying how to obtain and improve the iPSCs in people, pigs, cattle and other mammals.

The invention discloses a tissue engineering lymph node model and a construction method thereof and belongs to the technical field of tissue engineering and regenerative medicine. The tissue engineering lymph node model comprises lymphocytes separated from lymphoid tissues and a collagen-Matrigel scaffold. The construction method for the tissue engineering lymph node model comprises the following steps of: preparing lymphocyte suspension and primary generation mouse fibroblast cell suspension; and compounding mixed cell suspension and the collagen-Matrigel scaffold, and culturing in a mold subjected to static stretching to obtain the tissue engineering lymph node model. The scaffold system subjected to static stretching can better simulate in-vivo environment and support the growth and proliferation of the lymphocytes, secretion of cell factors and the expression of surface markers, and has important significance for applying the tissue engineering lymph node model to immunotoxicity evaluation of biological materials, immune medicine screening and the like. The construction method has the advantages of simple operating process and mild implementation conditions.

The invention discloses a preparation method of antibacterial silicone rubber. The preparation method comprises the following step: inducing ring opening polymerization of amino acid N-carboxylic acid anhydride in situ by virtue of amino on the surface of silicone rubber, so as to obtain the silicone rubber with the surface containing a polyamino acid copolymer or a polyamino acid homopolymer. According to the antibacterial silicone rubber prepared by virtue of the preparation method, the problems that existing antibacterial silicone rubber easily generates drug resistance and is poor in biocompatibility are solved, and the antibacterial silicone rubber has good application prospects. The antibacterial rate of the prepared antibacterial silicone rubber to bacteria including escherichia coli, staphylococcus aureus, staphylococcus epidermidis, pseudomonas aeruginosa, Candida albicans, pneumococcus and the like exceeds 90%, and the cytotoxicity of mouse fibroblast does not exceed level 1.

Disclosed is a simple method of determining SPF based on the staining pattern of viable cells like mouse fibroblasts and human keratinocytes after exposure to ultraviolet radiations. The method provides results comparable to the standard methods of SPF measurement using human subjects.

The invention specifically relates to a chloroquine cholesterol derivative, and a preparation method and application thereof, belonging to the field of the chemical pharmaceutical industry. The chloroquine cholesterol derivative provided by invention has a structure as shown in a formula I which is described in the specification. The invention also provides the preparation method and application of the chloroquine cholesterol derivative. The chloroquine cholesterol derivative provided by the invention can effectively inhibit the proliferation of rat fibroblasts and treat pulmonary fibrosis, exerts anti-inflammatory effect, and offers a novel option for preparation of anti-fibrotic, anti-inflammatory and anti-tumor drugs.

The invention discloses a mouse fibroblast tumor cell strain HXLyAF-KBM and application thereof.The cell strain is derived from the bone marrow microenvironment in a human lymphoma cell nude mouse transplantation tumor model, the cell name of the cell strain is mouse lymphoma related fibroblast tumor cells HXLyAF-KBM, the preservation number is CCTCC NO: C2021106, the preservation date is December 9, 2021, and the preservation number is CCTCC NO: C2021106. The preservation unit is China Center for Type Culture Collection. The cell strain is a bone marrow-derived lymphoma-related mouse fibroblast tumor cell strain established for the first time at home and abroad, and can be applied to construction of a mouse fibroblast tumor animal model, a malignant bone marrow microenvironment model, a 3D tumor culture system and organoid system model, and a bone marrow microenvironment and lymphoma progress and drug resistance relationship model.

The invention discloses Tibetan ganoderma lucidum polysaccharide GLP-1 with antioxidant efficacy, a preparation method and application; wherein the ganoderma lucidum polysaccharide GLP-1 is extractedfrom Tibetan ganoderma lucidum powder, the polysaccharide content is 73.36%, the uronic acid content is 2.27%, the weight-average molecular weight is 6.31 kDa, and the protein content is extremely low. The Tibetan ganoderma lucidum polysaccharide GLP-1 is separated and prepared from Tibetan ganoderma lucidum for the first time, wherein the GLP-1 comprises mannose, glucose, galactose, xylose, arabinose and the like, has characteristic absorption peaks of OH, CH, COH, alpha isomeric pyranose and alpha, beta glucosidic bonds, does not have a triple helix structure, and is good in thermal stability; besides, the obtained polysaccharide GLP-1 has chemical antioxidant activity, can protect mouse fibroblasts NIH3T3 from oxidative damage caused by tert-butyl hydroperoxide induction, and has good edible and medicinal values in the aspect of antioxidant activity.

The invention discloses a method for efficiently localizing exogenous mammal cytoplasmic protein in a cell nucleus and application thereof. According to the method, a pRK5-Sufu-GFP expression vector is digested by utilizing SalI single enzyme, then NLS is ligated into the vector by utilizing ligase, subsequently nuclear localization vectors pRK5-Sufu-nNLS-GFP (SnNG) with unequal numbers of inserted NLSs are obtained by transformation, and finally cytoplasmic protein is successfully localized in the cell nucleus. In the method disclosed by the invention, multiple NLSs can be inserted at one time, inserted n plasmid vectors (n being 1-5) are obtained simultaneously, and the exogenous cytoplasmic protein can be efficiently localized in the cell nucleus. The transfection of the plasmid into mouse fibroblasts (MEFs) is achieved by one-time construction of the cytoplasmic protein with 1-5 NLSs, so as to study the dose-effect relationship between the localization of the cytoplasmic protein incytoplasm/karyon and the biological activity and function of the cytoplasmic protein in cells.